MyndTec Inc. Closes Previously Announced Shares for Debt Transaction
Mississauga, Ontario--(Newsfile Corp. - July 13, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological...
Brain
CCA Industries, Inc. Announces Death of a Director
FORT WASHINGTON, PA / ACCESSWIRE / July 13, 2023 / CCA Industries, Inc. (OTC PINK:CAWW) is sad to announce the...
IQ-AI Announces Orphan Drug Designation for GaM in Pediatric GBM
MILWAUKEE, WI / ACCESSWIRE / July 13, 2023 / Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE:IQAI)(OTCQB:IQAIF),...
Ovaterra’s Advanced Prenatal Vitamins Provide Full Daily Choline Recommendation for Breastfeeding Mothers
Research shows that taking the full daily recommended amount of choline can play a crucial role in supporting maternal health...
Beckley Retreats Advances Research to Combat Veteran Suicide Through Psychedelic Retreats
Heroic Hearts Project and Imperial College London Have Partnered with Beckley Retreats to Research Psychedelic-Assisted Therapies for VeteransLONDON, July 13,...
Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology...
XVIVO Presents Interim Report January-June 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) "Continued momentum for our business"Second quarter 2023...
INmune Bio Inc. to Deliver Keynote Talk at 5th World Aging and Rejuvenation Conference.
RJ Tesi MD, CEO of INmune Bio, to Present Opening Keynote on Drug Development Strategies to Improve Health Span by...
IRBM, Rainwater Charitable Foundation and Weill Cornell Medicine Join Forces to Progress Therapies for Neurodegenerative Disorders
Multi-year drug discovery collaboration to identify small molecule cGAS inhibitors for treating neurodegenerative diseases including Alzheimer’sROME, July 12, 2023 (GLOBE...
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care
In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke...
Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.
COLLEGE STATION, TX / ACCESSWIRE / July 11, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics, Inc. ("ENZC" or the "Company")...
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
Stryker’s navigation system offers surgeons a comprehensive planning and guidance solution for complex cranial procedures.LEESBURG, Va.--(BUSINESS WIRE)--Stryker (NYSE: SYK), one...
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
Stryker’s navigation system offers surgeons a comprehensive planning and guidance solution for complex cranial procedures.LEESBURG, Va.--(BUSINESS WIRE)--Stryker (NYSE: SYK), one...
ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
Ocean Biomedical’s (NASDAQ: OCEA) mRNA-based Vaccine Candidate Generates Over 90% Killing of Malaria Parasites in Non-human Primates, Demonstrating Broad Potential for Ocean’s Program to Address Global and Emerging U.S. Malaria Challenges
Multiple Patents have been received in the U.S. and Internationally for Novel Vaccine Candidate and “Whole New Class” of Malaria...
INmune Bio Inc. Announces Novel MRI Biomarker Data Demonstrating Improvement in Gray Matter in Patients with Alzheimer’s Disease
Analysis of MRI scans in participants from an open label Phase 1b study demonstrates that CDM®, a novel gray matter biomarker, is improved following three months of treatment with XPro1595TM Boca Raton, Florida,...
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE)...
BrainsWay Accelerates International Expansion in India
Multisystem Purchases by Asha Neuromodulation Clinics (ANC) Allow for Increased Access to Deep TMS™BURLINGTON, Mass. and JERUSALEM, July 11, 2023...
AlzeCure Publishes New Disease Modifying Data with NeuroRestore ACD856 Against Alzheimer’s and Cognitive Disorders
STOCKHOLM, SWEDEN / ACCESSWIRE / July 11, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...